XML 116 R102.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Stock Appreciation Rights) (Details) (SARs, USD $)
12 Months Ended
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Shares Subject to SARs Outstanding & Exercisable 21,292pebo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestExercisableNumber
Weighted-Average Remaining Contractual Life 2 years 6 months
Number of Common Shares Subject to SARs  
Outstanding at January 1 (in shares) 21,292us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Outstanding at December 31 (in shares) 21,292us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Weighted- Average Exercise Price  
Outstanding at January 1 (in dollars per share) $ 25.96us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
Outstanding at December 31 (in dollars per share) $ 25.96us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
Weighted - Average Grant Date Fair Value  
Exercisable at December 31 (in shares) 21,292pebo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber
Exercisable at December 31 (in dollars per share) $ 25.96pebo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice
Outstanding at December 31, Weighted-Average Remaining Contractual Life 2 years 6 months
Exercisable at December 31, Weighted-Average Remaining Contractual Life 2 years 6 months
Outstanding at December 31 $ 28,000pebo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingIntrinsicValue
Exercisable at December 31 $ 28,000pebo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableIntrinsicValue
Exercise Price $23.26
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise Price $ 23.26us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ pebo_EquityInstrumentsOtherThanOptionsByExercisePriceAxis
= pebo_ExercisePriceOneMember
Number of Shares Subject to SARs Outstanding & Exercisable 2,000pebo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestExercisableNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ pebo_EquityInstrumentsOtherThanOptionsByExercisePriceAxis
= pebo_ExercisePriceOneMember
Weighted-Average Remaining Contractual Life 2 years 7 months
Exercise Price $23.77
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise Price $ 23.77us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ pebo_EquityInstrumentsOtherThanOptionsByExercisePriceAxis
= pebo_ExercisePriceTwoMember
Number of Shares Subject to SARs Outstanding & Exercisable 10,582pebo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestExercisableNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ pebo_EquityInstrumentsOtherThanOptionsByExercisePriceAxis
= pebo_ExercisePriceTwoMember
Weighted-Average Remaining Contractual Life 2 years 11 months
Exercise Price $29.25
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise Price $ 29.25us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ pebo_EquityInstrumentsOtherThanOptionsByExercisePriceAxis
= pebo_ExercisePriceThreeMember
Number of Shares Subject to SARs Outstanding & Exercisable 8,710pebo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestExercisableNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ pebo_EquityInstrumentsOtherThanOptionsByExercisePriceAxis
= pebo_ExercisePriceThreeMember
Weighted-Average Remaining Contractual Life 2 years 0 months